Glutamate antagonists for Parkinson's disease - Rationale for use and therapeutic implications

Alison J. Cooper^*, Camille B. Carroll, Ian J. Mitchell

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{cb049c9120a14b3fa6454d96aebcc565,

title = "Glutamate antagonists for Parkinson's disease - Rationale for use and therapeutic implications",

author = "Cooper, {Alison J.} and Carroll, {Camille B.} and Mitchell, {Ian J.}",

year = "1998",

doi = "10.2165/00023210-199809060-00001",

language = "English",

volume = "9",

pages = "421--429",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis International Ltd",

number = "6",

}

TY - JOUR

T1 - Glutamate antagonists for Parkinson's disease - Rationale for use and therapeutic implications

AU - Cooper, Alison J.

AU - Carroll, Camille B.

AU - Mitchell, Ian J.

PY - 1998

Y1 - 1998

U2 - 10.2165/00023210-199809060-00001

DO - 10.2165/00023210-199809060-00001

M3 - Article

SN - 1172-7047

VL - 9

SP - 421

EP - 429

JO - CNS Drugs

JF - CNS Drugs

IS - 6

ER -